# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA1659755 | F | Antimicrobial activity against Trypanosoma evansi STIB 806K infected in NMRI mouse assessed as complete cure from microbial infection at 2 mg/kg, ip administered 3 to 6 days after infection for 4 consecutive days | Trypanosoma evansi | 11 | organism-based format | Scientific Literature | ||
2. | ALA1659756 | F | Antimicrobial activity against Trypanosoma evansi STIB 806K infected in NMRI mouse assessed as host survival days at 2 mg/kg, ip administered 3 to 6 days after infection for 4 consecutive days | Trypanosoma evansi | 17 | organism-based format | Scientific Literature | ||
3. | ALA1659761 | F | Antimicrobial activity against Trypanosoma evansi STIB 806K infected in NMRI mouse assessed as host survival days at 0.125 mg/kg, ip administered 3 to 6 days after infection for 4 consecutive days | Trypanosoma evansi | 7 | organism-based format | Scientific Literature | ||
4. | ALA1660231 | F | Antimicrobial activity against Trypanosoma evansi STIB 806K infected in NMRI mouse assessed as host survival days at 0.5 mg/kg, ip administered 3 to 6 days after infection for 4 consecutive days | Trypanosoma evansi | 21 | organism-based format | Scientific Literature | ||
5. | ALA1660232 | F | Antimicrobial activity against Trypanosoma evansi STIB 806K infected in NMRI mouse assessed as host survival days at 0.25 mg/kg, ip administered 3 to 6 days after infection for 4 consecutive days | Trypanosoma evansi | 9 | organism-based format | Scientific Literature | ||
6. | ALA1660236 | F | Antimicrobial activity against Trypanosoma evansi STIB 806K infected in NMRI mouse assessed as complete cure from microbial infection at 0.5 mg/kg, ip administered 3 to 6 days after infection for 4 consecutive days | Trypanosoma evansi | 14 | organism-based format | Scientific Literature |